Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus versus Advagraf after de novo liver transplantation
NL-OMON55491Phase 4Active, not recruiting
- Sponsor
- Stichting Leveronderzoek
- Start
- Apr 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in liver transplant (2 arms), sponsored by Stichting Leveronderzoek. Primary endpoint: Primary composite endpoint. Started Apr 2019; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
liver transplant
Beyond the preview
Go deeper on NL-OMON55491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55491.